Medirom Healthcare Technologies Inc. has announced the issuance of its Fourth Unsecured Convertible-Type Corporate Bonds with Share Options, with an aggregate principal amount of JPY 275,000,000. The bonds were subscribed to by Kufu Company Holdings Inc., with the sale closing on December 31, 2025. The new bonds were issued in denominations of JPY 25,000,000. This development follows the maturity of the company’s previous convertible bonds, initially issued in December 2022 with a total value of JPY 500,000,000. Of the maturing amount, JPY 275,000,000 was refinanced via the new bond issuance, while the remaining JPY 25,000,000 principal was repaid in cash. As additional security, Medirom pledged all shares of its subsidiary, MEDIROM MOTHER Labs Inc., to the bondholder under a share pledge agreement executed on January 30, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-009932), on February 04, 2026, and is solely responsible for the information contained therein.